AFC-HD AMS Life Science Co., Ltd. (TYO:2927)
Japan flag Japan · Delayed Price · Currency is JPY
825.00
-22.00 (-2.60%)
Nov 6, 2026, 3:30 PM JST

AFC-HD AMS Life Science Cash Flow Statement

Millions JPY. Fiscal year is Sep - Aug.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Net Income
1,9682,2001,9101,5451,235
Depreciation & Amortization
1,4751,3961,0849831,005
Loss (Gain) From Sale of Assets
445426-223188
Loss (Gain) From Sale of Investments
-18-11-47-44-10
Other Operating Activities
-820-756-567-318-679
Change in Accounts Receivable
-340-147156-206-332
Change in Inventory
-628-890-1,433-633123
Change in Accounts Payable
-390-58351-261679
Change in Other Net Operating Assets
-14-374108-232-617
Operating Cash Flow
1,6781,7861,5408651,492
Operating Cash Flow Growth
-6.05%15.97%78.03%-42.02%-42.22%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Capital Expenditures
-2,403-3,538-3,406-1,939-957
Sale of Property, Plant & Equipment
16144658-3
Cash Acquisitions
--162-1142
Investment in Securities
-814151-188254388
Other Investing Activities
203171364-513
Investing Cash Flow
-2,853-3,326-2,761-1,946-1,077

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Short-Term Debt Issued
4961,0651,0031,0932,853
Long-Term Debt Issued
5231,3572,1721,684635
Total Debt Issued
1,0192,4223,1752,7773,488
Long-Term Debt Repaid
-1,520-1,177-487-380-1,034
Total Debt Repaid
-1,520-1,177-487-380-1,034
Net Debt Issued (Repaid)
-5011,2452,6882,3972,454
Issuance of Common Stock
258----
Repurchase of Common Stock
--13--79-288
Common Dividends Paid
-514-434-418-385-421
Other Financing Activities
141-132-38-52-586
Financing Cash Flow
-6166662,2321,8811,159

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Foreign Exchange Rate Adjustments
222-2316
Miscellaneous Cash Flow Adjustments
-2-11-
Net Cash Flow
-1,769-8701,0088041,590

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Free Cash Flow
-725-1,752-1,866-1,074535
Free Cash Flow Growth
-----74.41%
Free Cash Flow Margin
-2.11%-5.37%-6.18%-4.20%2.33%
Free Cash Flow Per Share
-50.13-124.54-132.80-76.4337.89
Levered Free Cash Flow
-1,126-2,330-1,029-1,497-66.13
Unlevered Free Cash Flow
-959.63-2,205-965.5-1,461-30.5

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23 Aug '22
Cash Interest Paid
288193975858
Cash Income Tax Paid
830798575282993
Change in Working Capital
-1,372-1,469-818-1,332-147